Mechanism of action of a novel series of naphthyridine-type ribosome inhibitors: enhancement of tRNA footprinting at the decoding site of 16S rRNA.
The novel ribosome inhibitors (NRIs) are a broad-spectrum naphthyridine class that selectively inhibits bacterial protein synthesis (P. J. Dandliker et al., Antimicrob. Agents Chemother. 47:3831-3839, 2003). Footprinting experiments, using a range of NRIs and chemical modification agents on Escherichia coli ribosomes, revealed no evidence for direct protection of rRNA. In the presence of tRNA, however, we found that NRIs enhanced the known ribosomal footprinting pattern of tRNA in a dose-dependent manner. The most prominent increase in protection, at A1492/3 and A1413 in helix-44 of 16S RNA, strictly required the presence of tRNA and poly(U), and the effect was correlated with the potency of the inhibitor. Radioligand binding studies with inhibitor [(3)H]A-424902 showed that the compound binds to tRNA, either in its charged or uncharged form. The dissociation constant for [(3)H]A-424902 binding to Phe-tRNA(Phe) was determined to be 1.8 microM, near its translation inhibition potency of 1.6 muM in a cell-free S. pneumoniae extract assay. The compound did not change the binding of radiolabeled tRNA to the 30S ribosomal subunit. Taken together, these results imply that the NRIs exert their effects on protein synthesis by structurally perturbing the tRNA/30S complex at the decoding site.
Shen
Linus L
LL
Abbott Laboratories, 100 Abbott Park Rd., Abbott Park, IL 60064-6099, USA. linus.l.shen@abbott.com.
Black-Schaefer
Candace
C
Cai
Yingna
Y
Dandliker
Peter J
PJ
Beutel
Bruce A
BA
D001345:Autoradiography; D001426:Bacterial Proteins / Q000096:biosynthesis / Q000235:genetics; D017931:DNA Primers; D015964:Gene Expression Regulation, Bacterial; D008958:Models, Molecular; D009287:Naphthyridines / Q000494:pharmacology*; D014176:Protein Biosynthesis; D023302:Protein Footprinting; D012336:RNA, Ribosomal, 16S / Q000187:drug effects*; D012343:RNA, Transfer / Q000096:biosynthesis* / Q000235:genetics; D011869:Radioligand Assay; D012270:Ribosomes / Q000187:drug effects*; D013296:Streptococcus pneumoniae / Q000187:drug effects / Q000235:genetics
D001426:Bacterial Proteins; D017931:DNA Primers; D009287:Naphthyridines; D012336:RNA, Ribosomal, 16S; D012343:RNA, Transfer